Can a Breast Abscess Be a Sign of Cancer?

Most breast abscesses are straightforward infections, but in a small fraction of cases an abscess can conceal an underlying malignancy or be the first sign that something more serious is developing. Reported rates vary, with one large review placing the figure below one percent and another surgical series finding cancer in the abscess wall in roughly one out of every twenty cases. The overlap in symptoms between a simple infection and breast cancer, particularly inflammatory breast cancer, makes this an area where the right follow-up matters enormously.

How Often Cancer Is Found Alongside a Breast Abscess

The honest answer is that the numbers depend on who is being studied and how thoroughly the abscess tissue is examined. A review spanning 20 studies and nearly a thousand breast abscess cases identified inflammatory carcinoma in about 0.6% of them.¹ That is a reassuringly low number. But a separate surgical series that routinely biopsied the abscess cavity wall after ultrasound-guided drainage found malignancy in about 4% of patients over a ten-year period, nine cancers among 206 drained abscesses.² The difference likely reflects how aggressively clinicians look. When every abscess wall gets a tissue sample, more hidden cancers turn up. When only suspicious-looking cases get biopsied, some go undetected.

That same surgical series reported a reassuring flipside: none of the 197 patients whose biopsy came back negative later returned with breast cancer.² In other words, once cancer has been properly ruled out, a benign abscess stays benign. The concern is not that an abscess eventually becomes cancerous. It is that a cancer was there all along, hiding behind the infection.

Why Breast Cancer and Breast Abscess Can Look So Similar

Both conditions can produce a painful, swollen lump with redness and skin thickening. Both can cause the skin to feel warm. On imaging, both can appear as an irregular mass or an area of architectural distortion that raises suspicion. This overlap is well recognized and makes diagnosis genuinely difficult, even for experienced clinicians.³ The confusion runs in both directions: abscesses get mistaken for cancer, prompting unnecessary alarm, and cancer gets mistaken for an abscess, delaying treatment.

The cancer type most notorious for mimicking infection is inflammatory breast cancer. Unlike a typical tumor that grows as a discrete lump, inflammatory breast cancer spreads through the lymphatic channels just beneath the skin, producing swelling, redness, and a peau d’orange texture (skin that looks like the surface of an orange). These features are nearly identical to what you see in mastitis or a developing abscess. MRI can sometimes help distinguish the two, but even advanced imaging does not always settle the question.⁴

Rarer cancer types can pull the same trick. Squamous cell carcinoma of the breast makes up less than 0.1% of invasive breast cancers, but when it does occur, it has a well-documented tendency to present as what looks like a straightforward abscess.⁵ Case reports describe patients treated with repeated rounds of drainage and antibiotics before anyone performed a biopsy revealing cancer underneath.⁶ These cases are individually uncommon, but the pattern is consistent enough that researchers have called for routine biopsy in all breast abscesses, not just suspicious ones.⁷

Inflammatory Breast Cancer During Pregnancy

One particularly treacherous scenario involves pregnant or recently pregnant women. Breast changes during pregnancy are expected: the tissue becomes denser, lumpier, and sometimes painful. If an infection or abscess develops, it is easy for both the patient and the doctor to attribute it to the hormonal upheaval of pregnancy and move on. But inflammatory breast cancer can appear during pregnancy, and it can look exactly like a pregnancy-related infection. A published case describes a woman at 16 weeks pregnant whose inflammatory breast carcinoma was initially treated as a simple abscess, leading to a delayed diagnosis with significant psychological and medical consequences.⁸

The takeaway for pregnant and postpartum women is not panic but awareness. Most breast infections during and after pregnancy are just infections. But if one does not respond to a full course of antibiotics, or if it comes back after drainage, that warrants a closer look.

Why It Matters Whether You Are Breastfeeding

The distinction between lactational and non-lactational breast problems turns out to be one of the most useful pieces of clinical information for gauging cancer risk. A large population study found that women with non-lactational mastitis (breast inflammation unrelated to breastfeeding) had roughly double the risk of later developing breast cancer compared to women without a history of mastitis, with an adjusted hazard ratio of about 1.94.⁹ The risk was particularly elevated in women under 50 and in women who had multiple episodes of non-lactational mastitis.

Women with lactational mastitis, the kind tied to breastfeeding, did not show a statistically significant increase in breast cancer risk.⁹ This makes biological sense: breastfeeding-related infections have a clear mechanical cause (clogged ducts, cracked nipples, bacteria entering the breast tissue), and once they resolve, the underlying tissue is usually normal. Non-lactational inflammation, on the other hand, may point to processes in the breast that are not as easily explained, and that ambiguity is part of what raises the index of suspicion.

This does not mean that non-lactational mastitis causes cancer. It means that something about the breast environment in women who develop inflammation outside of breastfeeding correlates with a higher cancer risk down the road. Whether that is chronic ductal damage, hormonal factors, or the inflammation itself somehow promoting abnormal cell growth is still being worked out.

Benign Conditions That Also Mimic Cancer

The diagnostic confusion is not limited to abscesses hiding cancer. Several benign inflammatory conditions of the breast can produce imaging findings and clinical signs that closely resemble malignancy, leading to unnecessary biopsies and considerable patient anxiety. Being aware of these conditions helps put the “is it cancer?” question in proper context.

Granulomatous lobular mastitis is a rare chronic inflammatory disease with no known cause. It produces masses, skin changes, and imaging abnormalities that can be nearly indistinguishable from invasive breast cancer.¹⁰ The condition often leads to repeated biopsies before the correct diagnosis is reached. Treatment involves a combination of medical therapy and sometimes surgery to manage the inflammation and reduce recurrence, and the long-term prognosis is good once the diagnosis is clear.¹¹

Zuska’s disease is another chronic condition in which a fistula forms between a breast duct and the skin surface, often near the nipple. It tends to cause recurring abscesses and drainage. On mammography, it can produce skin thickening, ill-defined masses, and architectural distortion, all findings that overlap with what breast cancer looks like on imaging. For that reason, any inflammatory breast mass that does not improve with standard treatment should be biopsied to rule out malignancy.¹²

These conditions are frustrating because they can bounce between looking like cancer on a scan and looking like an infection in the clinic. The practical lesson is the same one that applies to abscesses more broadly: imaging alone cannot always tell the story, and tissue sampling is the definitive tiebreaker.

Red Flags That Justify a Biopsy

Not every breast abscess needs an aggressive cancer workup. The large majority of abscesses, especially in young breastfeeding women, are exactly what they appear to be. But certain patterns should prompt your doctor to look deeper:

• No response to antibiotics: A true infection should start improving within a few days of appropriate antibiotic treatment. An abscess that persists or worsens despite drainage and antibiotics is not behaving like a simple infection.
• Recurrence: An abscess that keeps coming back in the same area after apparently successful treatment deserves a tissue biopsy, particularly if the patient is not breastfeeding.
• Non-lactational context: An abscess or inflammatory breast condition in a woman who is not breastfeeding and has no obvious cause (such as a recent nipple piercing or prior surgery) warrants a lower threshold for biopsy.
• Skin changes beyond simple redness: Peau d’orange texture, nipple retraction, or skin dimpling that persists after the acute infection resolves are findings that overlap more with cancer than with routine infection.
• Age over 50: Breast abscesses become less common with age, and the baseline probability of breast cancer increases. An abscess in an older woman who is not breastfeeding is statistically more likely to harbor something unexpected.

The question of whether to biopsy every breast abscess regardless of clinical suspicion remains debated. Some researchers argue that routine cavity wall biopsy during drainage is justified by the roughly 4% malignancy rate found in surgical series.² Others consider that rate inflated by referral bias, since the patients reaching a surgical practice may already be the ones with more complex presentations. In practice, the decision often comes down to how many risk factors are stacking up for a given patient.

The Misdiagnosis Problem

Inflammatory breast cancer accounts for a small fraction of all breast cancers, but its outcomes are disproportionately poor, partly because it is so often initially misdiagnosed. Patient advocacy accounts describe a disturbingly common story: a woman notices skin changes or swelling, sees a doctor, is told it is mastitis or an abscess, gets antibiotics, and does not receive imaging or biopsy until weeks or months later when the symptoms refuse to resolve.³ By then, the cancer may have progressed.

This delay matters. Research on breast cancer more broadly shows that diagnostic delays significantly increase the odds of being diagnosed at a later stage. One study found that patients who waited more than about two months from recognizing symptoms to seeing a provider had nearly seven times the odds of presenting with advanced disease compared to those who sought care sooner.¹³ The same study found that a diagnostic delay of roughly seven weeks or more, from first presentation to a provider to an actual diagnosis, nearly doubled the odds of late-stage disease. While these numbers come from a specific population and may not generalize perfectly, the direction of the effect is consistent across the literature: delay costs staging ground.

The challenge is that the initial misdiagnosis is often reasonable. A breast that is red, swollen, and painful does look infected. Antibiotics are a sensible first step. The failure point is not the first visit. It is what happens when the antibiotics do not fully work, or when the symptoms come back. If the follow-up plan is to simply try another round of antibiotics without imaging or biopsy, an underlying cancer can sit undetected for months.

What the Breast Microbiome May Reveal

An emerging area of research that could eventually change how doctors assess breast tissue involves the microbiome of the breast itself. Most people associate the microbiome with the gut, but breast tissue also harbors microbial communities, and these communities appear to differ between healthy tissue, benign disease, and malignancy. A study comparing breast tissue from women with cancer to tissue from women with benign breast conditions found that malignant tissue was enriched in several bacterial genera that were relatively uncommon in benign tissue.¹⁴

This is not yet clinically useful. Nobody is running a breast microbiome test as part of abscess workup today. But it raises interesting questions about whether the bacterial environment of the breast plays a role in cancer development, or whether cancer alters the tissue environment in ways that favor certain bacteria. If future research can identify reliable microbial signatures that distinguish infection-only tissue from tissue harboring early malignancy, it could eventually provide a new tool for deciding which abscesses deserve closer attention. For now, the standard remains what it has been for decades: if the clinical picture is at all ambiguous, get tissue under a microscope.